• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELEMENT PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9388
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems No Consequences Or Impact To Patient (2199); Device Embedded In Tissue or Plaque (3165)
Event Date 07/02/2020
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that stent dislodgement occurred.The patient presented with vessel occlusion.A 3.50x24mm promus element plus drug-eluting stent was advanced for treatment.However, during the procedure, the stent was dislodged.The procedure was not completed due to this event.No patient complications were reported and the patient status was stable.
 
Event Description
It was reported that stent dislodgement occurred.The patient presented with vessel occlusion.A 3.50x24mm promus element plus drug-eluting stent was advanced for treatment.However, during the procedure, the stent was dislodged.The procedure was not completed due to this event.No patient complications were reported and the patient status was stable.It was further reported that vascular access was obtained via radial artery and the target lesion was 80% stenosed and 80% calcified.The final location of the dislodged stent was on the left anterior descending artery.The device was not completely removed from the patient's body and the procedure was completed by implanting the second stent at the lesion.
 
Manufacturer Narrative
A promus element plus,mr,ous 3.50x24mm stent delivery system was returned for analysis without the stent.An examination of the crimped stent found that the stent was not returned with the device.A review of the manufacturing stent profile data was performed and the stent od (outer diameter) at the time of manufacture was within maximum crimped stent profile measurement.The balloon cones were reviewed, and signs of positive pressure applied to the cones were noted as its wings were relaxed and not tightly folded.A visual and microscopic examination of the bumper tip showed no signs of tip damage.A visual and tactile examination of the hypotube shaft found no issues.A visual and tactile examination of the outer and mid-shaft section found a kink in the midshaft section with the core wire also bent and measured at 260mm proximal to distal end of tip.Bunching of the inner shaft polymer extrusion was noted measured at 66mm proximal to distal end of tip.Additionally, the guidewire exchange port was noted to present a tear 4mm in length distal to the exchange port.No other issues were identified during the product analysis.A cd containing a series of angiographic images was returned with the complaint device and reviewed.A guide catheter was in position at the lm(left main) ostium and contrast flow assessment of the left main arteries showed views of the left main coronary arteries.No treatment of any lesions were noted in lm arteries and no attempts to deploy a stent or a dislodgement of any stent was noted.The remaining series showed treatment of rca(right coronary artery) with views under flow contrast noting the distal end of the guide catheter positioned at the ostium of rca and a lesion site identified as a constricted region in the proximal rca.A guidewire was seen placed trough rca without any pre dilations being noted.A stent was seen placed and deployed at the lesion site followed by assessment which showed no significant improvement in the flow at the lesion site.Another stent was seen being positioned at the proximal end of the first one and deployed, however, no further images were available to asses if this second deployment was successful in opening the narrowing present in proximal rca.A review of the media provided could not identify the alleged stent dislodgement as the only 2 stents visible in the images provided were deployed at a lesion site in proximal rca without any issues.The event description mentions that the alleged dislodgement took place in lad(left anterior descending), however, no treatment of lad could be noted in the images reviewed.
 
Manufacturer Narrative
Corrected h6 patient codes.Updated b5: describe event or problem.
 
Event Description
It was reported that stent dislodgement occurred.The patient presented with vessel occlusion.A 3.50x24mm promus element plus drug-eluting stent was advanced for treatment.However, during the procedure, the stent was dislodged.The procedure was not completed due to this event.No patient complications were reported and the patient status was stable.It was further reported that vascular access was obtained via radial artery and the target lesion was 80% stenosed and 80% calcified.The final location of the dislodged stent was on the left anterior descending artery.The device was not completely removed from the patient's body and the procedure was completed by implanting the second stent at the lesion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10265017
MDR Text Key198555870
Report Number2134265-2020-09066
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 08/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/02/2021
Device Model Number9388
Device Catalogue Number9388
Device Lot Number0023457323
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/23/2020
Date Manufacturer Received08/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient Weight65
-
-